Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction

IF 11.8 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Heart failure Pub Date : 2025-09-09 DOI:10.1016/j.jchf.2025.102626

Jerome Roncalli MD, PhD , François Roubille MD, PhD , Yves Cottin MD, PhD , Lionel Leroux MD, PhD , Anthony Mathur MD, PhD , John Irving MD , Sohail Q. Khan MB ChB, MD , Nicolas Meneveau MD, PhD , Didier Bresson MD , Thomas Hovasse MD , Giulio Pompilio MD, PhD , Anthony Matta MD, PhD , Philippe Henon MD , Guillaume Trebuchet PhD , Matthieu de Kalbermatten MS, MBA , Ibon Garitaonandia PhD, MBA , Eric Saloux MD, PhD , Alain Manrique MD, PhD , Nicolas Meyer MD, PhD , Pierre-Yves Marie MD, PhD , Frédéric Bouisset

引用次数: 0

查看原文本刊更多论文

心肌梗死后经心内膜注射扩增的自体CD34+细胞

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JACC. Heart failure CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

21.20

自引率

2.30%

发文量

164

期刊介绍： JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.